
Détail de l'auteur
Auteur E. J. LAFORGUE |
Documents disponibles écrits par cet auteur (4)

![]()
Article : Périodique
A. AQUIZERATE ; E. J. LAFORGUE ; M. ISTVAN ; M. ROUSSELET ; M. GÉRARDIN ; E. JOUANJUS ; F. LIBERT ; French Addictovigilance Network ; M. GUERLAIS ; C. VICTORRI-VIGNEAU |BACKGROUND: Since the appearance of zolpidem on the market, the occurrence of serious cases of abuse, misuse and dependence have come to the attention of authorities. In view of the increase in the number and severity of cases among zolpidem use[...]![]()
Article : Périodique
M. GUILLOU-LANDREAT ; A. DANY ; G. CHALLET-BOUJU ; E. J. LAFORGUE ; J. CHOLET ; J. LEBOUCHER ; J. B. HARDOUIN ; C. VICTORRI-VIGNEAU ; M. GRALL-BRONNEC |BACKGROUND: The resurgence of heroin use and the misuse of pharmaceutical opioids are some of the reasons for a worldwide increase in opioid dependence. Opioid Medication Therapies (OMT) have amply demonstrated their efficacy. From a medical poi[...]![]()
Article : Périodique
M. GUERLAIS ; A. AQUIZERATE ; A. LIONNET ; A. DAVELUY ; M. DUVAL ; M. GÉRARDIN ; M. ISTVAN ; E. J. LAFORGUE ; C. VICTORRI-VIGNEAU |INTRODUCTION: Nitrous oxide has become over the last few years a public health problem in many countries. France has a dedicated health monitoring system dedicated to the surveillance of the abuse, dependence and consequences associated with the[...]![]()
Article : Périodique
M. GRALL-BRONNEC ; E. J. LAFORGUE ; G. CHALLET-BOUJU ; J. CHOLET ; J. B. HARDOUIN ; J. LEBOUCHER ; M. GUILLOU-LANDREAT ; C. VICTORRI-VIGNEAU ; OPAL Group |Background: Opioid use disorder (OUD) is a worldwide major health concern due to increased early mortality and morbidity. Opioid substitution therapy (OST) is approved in the context of a global OUD treatment (OUDT), in conjunction with psychoso[...]